Additive Manufacturing (Light Curing) Crown Bridge Resin

K250497 · Aidite (Qinhuangdao) Technology Co., Ltd. · EBF · Apr 30, 2025 · Dental

Device Facts

Record IDK250497
Device NameAdditive Manufacturing (Light Curing) Crown Bridge Resin
ApplicantAidite (Qinhuangdao) Technology Co., Ltd.
Product CodeEBF · Dental
Decision DateApr 30, 2025
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3690
Device ClassClass 2
AttributesTherapeutic

Intended Use

Additive Manufacturing (Light Curing) Crown Bridge Resin is a light-cured resin indicated for the fabrication of permanent single crowns in the anterior and posterior region, denture teeth, inlays, onlays, veneers and implant crown. It is also used for long-term provisional crowns and bridges.

Device Story

Liquid resin for dental 3D printing; composed of methacrylic acid esters, inorganic fillers, photoinitiators, and pigments. Used by dentists or dental technicians in clinical or laboratory settings to fabricate dental restorations via CAD/CAM workflows. Input: digital design files processed by DLP 3D printers (385nm or 405nm wavelengths). Output: physical dental restorations (crowns, bridges, etc.) post-cured via light-curing units. Enables patient-specific, permanent or long-term provisional dental prosthetics. Benefits include precise anatomical fit and efficient manufacturing.

Clinical Evidence

Bench testing only. Physical/mechanical properties evaluated per ISO 4049 and ISO 10477 (viscosity, hardness, flexural strength, water sorption/solubility, etc.). Biocompatibility testing performed per ISO 10993-1, ISO 10993-3, ISO 10993-5, ISO 10993-6, ISO 10993-10, ISO 10993-11, ISO 10993-23, and ISO 7405. No clinical data.

Technological Characteristics

Light-cured hybrid dental resin; methacrylic acid esters, inorganic filler, photoinitiator, pigments. Form factor: liquid in HDPE bottles. Curing: 385nm or 405nm light. Standards: ISO 4049, ISO 10477, ISO 10993, ISO 7405. Non-sterile. Shelf life: 3 years.

Indications for Use

Indicated for fabrication of permanent single crowns (anterior/posterior), denture teeth, inlays, onlays, veneers, implant crowns, and long-term provisional crowns and bridges. For use by dentists or dental technicians.

Regulatory Classification

Identification

Tooth shade resin material is a device composed of materials such as bisphenol-A glycidyl methacrylate (Bis-GMA) intended to restore carious lesions or structural defects in teeth.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} FDA U.S. FOOD & DRUG ADMINISTRATION April 30, 2025 Aidite (Qinhuangdao) Technology Co., Ltd % Boyle Wang Occupational Manager Shanghai Truthful Information Technology Co., Ltd RM.1801, No. 161, East Lu Jiazui Rd., Pudong Shanghai, 200120 CHINA Re: K250497 Trade/Device Name: Additive Manufacturing (Light Curing) Crown Bridge Resin Regulation Number: 21 CFR 872.3690 Regulation Name: Tooth Shade Resin Material Regulatory Class: Class II Product Code: EBF, EBG, POW, PZY Dated: February 20, 2025 Received: February 20, 2025 Dear Boyle Wang: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K250497 - Boyle Wang Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory- {2} K250497 - Boyle Wang Page 3 assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, MICHAEL E. ADJODHA -S Michael Adjodha, MChE, RAC, CQIA Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} FORM FDA 3881 (6/20) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF | DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use | Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below. | | --- | --- | | 510(k) Number (if known) K250497 | | | Device Name Additive Manufacturing (Light Curing) Crown Bridge Resin | | | Indications for Use (Describe) Additive Manufacturing (Light Curing) Crown Bridge Resin is a light-cured resin indicated for the fabrication of permanent single crowns in the anterior and posterior region, denture teeth, inlays, onlays, veneers and implant crown. It is also used for long-term provisional crowns and bridges. | | | Type of Use (Select one or both, as applicable) ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | | | CONTINUE ON A SEPARATE PAGE IF NEEDED. | | | This section applies only to requirements of the Paperwork Reduction Act of 1995. *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* | | | The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov | | | "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | | {4} 510(k) Summary # 510(k) Summary # K250497 This summary is submitted in accordance with 21 CFR 807.92. ## 1.0 Submission Sponsor Name: Aidite (Qinhuangdao) Technology Co., Ltd. Address: No.9 Dushan Road, Economic and Technological Development Zone, Qinhuangdao City, China 066004 Contact: Mr. Ye Zhanfu Tel: +86 335 8587898 Fax: +86 335 8587198 ## Designated Submission Correspondent Contact: Mr. Boyle Wang Address: Shanghai Truthful Information Technology Co., Ltd. Room 1801, No. 161 East Lu Jiazui Rd., Pudong Shanghai, 200120 China Tel: +86-21-50313932 Email: info@truthful.com.cn Date of Preparation: Apr.24,2025 ## 2.0 Device Information Trade name: EZPRINT™ CERAMIC CROWN Common name: Additive Manufacturing (Light Curing) Crown Bridge Resin Model: Monochromatic Classification name: Material, Tooth Shade, Resin Production code: EBF Regulation number: 21 CFR 872.3760 Classification: Class II Panel: Dental ## 3.0 Identification of Predicate Device and Reference Device Primary Predicate Device: 510(k) Number: K222877 Trade/Product Name: Freeprint denture 1 of page 6 {5} 510(k) Summary Manufacturer: DETAX GmbH Predicate Device 2: 510(k) Number: K233596 Trade/Product Name: VarseoSmile TriniQ Manufacturer: BEGO Bremer Goldschlagerei Wilh. Herbst GmbH & Co. KG ## 4.0 Device Description Additive Manufacturing (Light Curing) Crown Bridge Resin is a light-curing, hybrid dental material, composed of methacrylic acid esters, inorganic filler, photoinitiator, organic pigments, inorganic pigments and additives. It is Liquid resin for dental 3D printing of permanent single crowns in the anterior and posterior region, denture teeth, inlays, onlays, veneers and implant crown. It is also used for long-term provisional crowns and bridges. The Subject device is used by a dentist or dental technician for the CAD/CAM manufacturing of temporary or permanent dental restorations. For use in Digital Light Processing (DLP)- 3D printers utilizing wavelengths at 385nm or 405nm. The Subject device is packaged in black plastic bottles made of high density polyethylene (HDPE) according to the weight of the resin liquid. There are different shades A1, A2, A3, A3.5, A4, B1, B2, B3, B4, C1, C2, C3, C4, D2, D3, D4, BL1, BL2, BL3, BL4, and the different shades are reflected in the different colors of finished restorations. ## 5.0 Indication for Use Statement Additive Manufacturing (Light Curing) Crown Bridge Resin is a light-cured resin indicated for the fabrication of permanent single crowns in the anterior and posterior region, denture teeth, inlays, onlays, veneers and implant crown. It is also used for long-term provisional crowns and bridges. ## 6.0 Non-clinical Test Conclusion **Bench Testing:** - Physical and mechanical properties of the subject device were evaluated according to FDA-recognized version ISO 4049 Dentistry - Polymer-based restorative materials and ISO 10477 Dentistry - Polymer-based crown and veneering materials. Performance testing including Appearance, Viscosity, Density, Shade, Depth of cure, Surface finish, Vickers hardness, Flexural Strength, Water Sorption, Water Solubility, Bond strength, Shade consistency, Color stability and Accuracy. The test results demonstrated the Subject device meets the property requirements of the referenced standards. - Printers Validation: Two printers are validated for processing (3D printing) using the {6} 510(k) Summary candidate device. Additional printers post-510(k) clearance will be added to the labelling by means of the Quality Systems and within the validation plan presented in this 510(k). ## Biocompatibility Testing: The nature of body contact of materials used in the design of the Additive Manufacturing (Light Curing) Crown Bridge Resin were classified as being Surface Devices in contact with mucosal membrane with a permanent contact duration of >30 days. The biocompatibility testing was performed according to FDA currently-recognized versions of biocompatibility consensus standards ISO 10993-1:2018 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process and ISO 7405:2018 Dentistry – Evaluation of biocompatibility of medical devices used in dentistry. The following biological safety aspects have been addressed: - Cytotoxicity – ISO 10993-5 - Sensitization – ISO 10993-10 - Irritation – ISO 10993-23 - Acute Systemic Toxicity – ISO 10993-11 - Subchronic Systemic Toxicity – ISO 10993-11 - Genotoxicity – ISO 10993-3 - Implantation – ISO 10993-6 Sterility and Shelf-Life Testing: The device is provided non-sterile. From the Shelf life testing, Additive Manufacturing (Light Curing) Crown Bridge Resin has a shelf life of 3 years. ## 7.0 Technological Characteristics and Substantial Equivalence The following table shows similarities and differences of use, design, and material between our device and the predicate devices. Table 1- Comparison of Technology Characteristics 3 of page 6 {7} 510(k) Summary | Item | Subject Device | Primary Predicate Device | Predicate Device 2 | Remark | | --- | --- | --- | --- | --- | | 510(k) No. | K250497 | K222877 | K233596 | | | Product Name | Additive Manufacturing (Light Curing) Crown Bridge Resin | FREEPRINT® crown | VarseoSmile TriniQ | -- | | Product Code | EBF | EBF | EBF, EBG, PZY | Same | | Regulation No. | 21 CFR 872.3690 | 21 CFR 872.3690 | 21 CFR 872.3690 | Same | | Class | II | II | II | Same | | Intended Use/Indication for Use | Additive Manufacturing (Light Curing) Crown Bridge Resin is a light-cured resin indicated for the fabrication of permanent single crowns in the anterior and posterior region, denture teeth, inlays, onlays, veneers and implant crown. It is also used for long-term provisional crowns and bridges. | FREEPRINT® crown is indicated as an indirect restorative for both anterior and posterior restorations, including occlusal surfaces. The FREEPRINT® crown material is used for fabricating temporary or permanent restorations such as crowns and bridges, inlays, onlays, veneers and full crown restorations. Fabrication of FREEPRINT® crown requires a computer-aided and manufacturing (CAD/CAM) system that includes the following: scanner, design software, additive printer, and post-cure unit | VarseoSmile TriniQ is indicated as an indirect restorative for both anterior and posterior restorations, including occlusal surfaces. The VarseoSmile TriniQ material is used for fabricating permanent restorations such as inlays, onlays, veneers, full crown and bridge restorations. VarseoSmile TriniQ can also be used for the fabrication of artificial teeth and temporary crowns & bridges. | Same (Analysis 1) | | Prescription Use | Yes | Yes | Yes | Same | | Technology | 3D liquid (light-cured) print resin for dental CAD/CAM | 3D liquid (light-cured) print resin for dental CAD/CAM | 3D liquid (light-cured) print resin for dental CAD/CAM | Same | | Materials | Methacrylic acid esters, inorganic filler, photoinitiator, organic pigments, inorganic pigments and additives | Methacrylate polymer resin with photo initiator, and pigments | Methacrylate-based resins, dental glass filler, photo initiators and pigments | Similar | | Materials Shades | A1, A2, A3, A3.5, A4, B1, B2, B3, B4, C1, C2, C3, C4, D2, D3, D4, BL1, BL2, BL3, BL4 | Common VITA-shades: A1, A2, A3, B1, B3, C3, D3, BL | Common VITA-shades | Different (Analysis 2) | | Shelf-Life | 3 years | 2 years | Not publicly available | Different (Analysis 3) | 4 of page 6 {8} 510(k) Summary | Polymerization (Curing) Method | Visible light, 385 nm or 405nm w/post curing | Visible light, 385 nm w/post curing | UV light, 385 or 405 nm w/post curing | Different (Analysis 4) | | --- | --- | --- | --- | --- | | Equipment | Validated 3D-Printer and post curing devices | Validated 3D-Printer and post curing devices | Validated 3D-Printer and post curing devices | Same | | Performance Testing | ISO 4049:2019 ISO 10477:2020 | ISO 4049:2019 ISO 10477:2020 | ISO 4049:2019 ISO 10477:2020 ISO 22112:2017 | Same | | Depth of Cure | The hardness of the centre of the specimen of Additive Manufacturing (Light Curing) Crown Bridge Resin shall be not less than 70% of the hardness of its surface. | Hardness of bottom surface ≥70% top surface | Not publicly available | Same | | Surface Finish | A polished test specimen of Additive Manufacturing (Light Curing) Crown Bridge Resin shall have a glossy surface. | Glossy surface after polishing | Not publicly available | Same | | Flexural Strength | ≥ 50 MPa | ≥ 100 MPa | ≥ 100 MPa | Different (Analysis 5) | | Water Sorption | ≤ 40 μg/mm³ | ≤ 40 μg/mm³ | Not publicly available | Same | | Water Solubility | ≤ 7.5 μg/mm³ | ≤ 7.5 μg/mm³ | Not publicly available | Same | | Sterile | Non-sterile | Non-sterile | Non-sterile | Same | | Biocompatibility | Comply with ISO 10993-1:2018, and ISO 7405:2018 | Comply with ISO 10993-1, ISO 7405:2018 | Comply with ISO 10993-1, ISO 7405:2018 | Same | Analysis*: 1) The "Indication for Use" of Additive Manufacturing (Light Curing) Crown Bridge Resin and FREEPRINT® crown are considered substantially equivalent. Both products are intended for same uses. Additionally, both products can be used for temporary or long-term restorations, with fabrication involving CAD/CAM systems and light-curing technology, ensuring consistency in their intended clinical application. 2) The subject device provides a wider range of shades. The different color due to the composition in the content of pigments. These color variations do not raise new questions of safety or effectiveness, as both devices meet the required performance and biocompatibility standards. Therefore, the differences in color do not impact the substantial equivalence of the subject device to the predicate device. 3) The difference in shelf life between the two products does not impact their Substantial Equivalence. The shelf-life validation report of the subject device 5 of page 6 {9} 510(k) Summary demonstrates the stability of the products' performance over time, ensuring their reliability and safety during their respective shelf lives. 4) The subject Additive Manufacturing (Light Curing) Crown Bridge Resin and the predicate device share the same intended use and indication for use. The difference between the subject and predicate devices is the type of 3D printer and the range of wavelengths used in the printing process. While the subject device can be used with DLP 3D printers operating in a wider range of wavelengths (385nm to 405nm) that is same with that of K233596. The predicate device is limited to 3D printers using a 385nm light source. However, both devices are designed to utilize similar light-curing mechanisms and wavelengths that initiate the same polymerization process in the resin. These differences do not raise new questions regarding safety or effectiveness. Since both devices are designed for the same intended use, have similar technological principles, and meet the performance standards of ISO 4049:2019 and ISO 10477:2020, the differences do not affect their substantial equivalence. 5) Flexural Strength requirement between the subject device and the predicate device is different. Flexural Strength $\geqslant 50$ MPa meets the requirement specified by ISO 10477:2020, which sets the minimum standard for dental materials in terms of flexural strength. In addition, the actual test results for the subject device show that its Flexural Strength is consistently above $100\mathrm{MPa}$, which is in alignment with that of the predicate device, confirming that the two products are substantially equivalent in terms of their performance characteristics ## 8.0 Summary of Clinical Test Clinical testing was not required for this submission. ## 9.0 Conclusion The conclusions drawn from the comparison and analysis above demonstrate that the subject device is substantially equivalent to the legally marketed predicated device.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%